Repurposing Conventional Magnetic Functional Agents: A Novel Strategy for Long-Acting, Safe, Magnetically Mediated...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Conventional magnetic agents are limited to MRI or thermal ablation.
• Developing novel therapeutic applications for magnetic materials is crucial.

Purpose of the Study:

• To repurpose Fe3O4 nanoparticles and gadopentetic acid (GA) for enhanced magnetic field (MF) therapy in glioma.
• To investigate the synergistic effects of these magnetic agents with MF therapy.

Main Methods:

• Utilized Fe3O4 nanoparticles and GA as magnetic functional agents.
• Applied an external magnetic field (MF) in a CT-2A glioma mouse model.
• Assessed tumor growth inhibition (TGI), CD31 expression, microvessel density, and T-cell infiltration.

Main Results:

• MF therapy potentiated by Fe3O4 and GA significantly increased TGI rates to 64% and 55%, respectively, compared to MF alone (~27%).
• Enhanced MF therapy reduced tumor angiogenesis, evidenced by decreased CD31 expression and microvessel density.
• Disrupted tumor perfusion and reduced infiltration of CD4+ and CD8+ T cells were observed.

Conclusions:

• Established a novel paradigm for using conventional magnetic materials in glioma therapy.
• Demonstrated enhanced non-thermal physical and biological regulatory effects of MF therapy.
• Repurposed magnetic agents offer a new strategy beyond imaging or hyperthermia for cancer treatment.